Skip to content

Study on the difference of autonomic nerve function and central mechanism in different bone mass populations

Correlation between bone mass metabolism and autonomic nerve function

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054478
Enrollment
Unknown
Registered
2021-12-18
Start date
2021-12-18
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteopenia

Interventions

group of postmenopausal women with normal bone mass:None
postmenopausal women with osteopenia group:None
middle-aged and elderly male group with normal bone mass:None
middle-aged and elderly male group with osteopenia:None

Sponsors

The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women with normal bone mass: (1) Aged 50-70 years, menopause for more than 3 years, right-handed; (2) Able to understand the research content and cooperate to complete the research; (3) Subjects voluntarily participate in the research and sign the informed consent; (4) No contraindications for fMRI scanning; (5) No arrhythmia; (6) T-score > -1; (7) No serious underlying diseases including but not limited to systemic diseases such as heart, brain, liver and kidney. 2. Postmenopausal women with osteopenia: (1) Aged 50-70 years, menopause for more than 3 years, right-handed; (2) Able to understand the research content and cooperate to complete the research; (3) Subjects voluntarily participate in the research and sign the informed consent; (4) No contraindications for fMRI scanning; (5) No arrhythmia; (6) T-score -1; (7) No serious underlying diseases including but not limited to systemic diseases such as heart, brain, liver and kidney. 4. Middle-aged and elderly men with osteopenia: (1) Aged 50-70 years, right-handed; (2) Able to understand the research content and cooperate to complete the research; (3) Subjects voluntarily participate in the research and sign the informed consent; (4) No contraindications for fMRI scanning; (5) No arrhythmia; (6) T-score<-1; (7) No serious underlying diseases including but not limited to systemic diseases such as heart, brain, liver and kidney.

Exclusion criteria

Exclusion criteria: 1. There are implants or surgical treatment at the inspection site; 2. Inconvenient to move or extremely weak or mentally abnormal, unable to cooperate with the completion of the examination; 3. There is strenuous activity 24 hours before the examination; 4. There is a history of using tobacco, alcohol, tea, coffee, and energy drinks 24 hours before the inspection; 5. Abnormal body temperature or use of antipyretic and analgesic drugs within 3 days before the examination; 6. Use of drugs that affect heart rate variability, such as antihistamines, hypnotics, sedatives, opioids, metformin, etc., within 3 days before the examination; 7. The investigator believes that the patient has other conditions that are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
bone mineral density;heart rate variability;brain fMRI;

Secondary

MeasureTime frame
questionnaire;biomarker of bone metabolism;

Countries

China

Contacts

Public ContactLiu Bo
liubogzcm@163.com+86 13570112883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026